Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 study comparing ipilimumab with or without sargramostim in patients with unresectable Stage III or Stage IV melanoma, with results…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases [Phase 2]
This entry reports the completion and posted results of a Phase 2 neoadjuvant trial evaluating vemurafenib in melanoma patients with untreat…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: ADI-PEG in Patients With Metastatic Melanoma [Phase 1]
Phase 1 study of ADI-PEG 20 in patients with metastatic melanoma has completed, yielding preliminary safety and tolerability data.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Intratumoral Injection Of Alpha-Gal Glycosphingolipids [Phase 1]
Phase 1 clinical trial of intratumoral alpha-gal glycosphingolipids in metastatic melanoma has completed.
-
CLINICAL_TRIALS withdrawal · 2015-03-13Clinical Trial Update: A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma [Phase 1]
The Phase I trial of normothermic isolated limb infusion with melphalan plus buthionine sulfoximine (BSO) for locally advanced malignant mel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion [Phase 1]
Phase 1 study evaluating safety and tolerability of intra-arterial temozolomide delivered by isolated limb infusion in patients with extremi…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: EF5 in Melanoma Patients [Phase 1]
Phase 1 trial of EF5 in melanoma patients has completed. This document provides an update on the study status.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg [Phase 1]
This Phase 1 study evaluating Sorafenib with isolated limb infusion of melphalan for stage III melanoma of the arm or leg has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma [Phase 2]
Phase 2 trial of ILX651 in inoperable locally advanced or metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A Phase II Study of UCN-01 in Metastatic Melanoma [Phase 2]
A Phase II trial of UCN-01 in metastatic melanoma was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy
A completed clinical trial evaluated the combination of in situ immunotherapy and laser therapy for advanced malignant melanoma.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies [Phase 1]
A Phase 1 study of MDX-1106 in patients with selected refractory or relapsed malignancies has completed, with results posted in 2015. The tr…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma [Phase 1, Phase 2]
This update reports the completion of a Phase I/II clinical trial of CR011-vcMMAE in patients with unresectable stage III or stage IV melano…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine [Phase 1]
Phase 1 trial comparing dendritic cells versus Montanide as adjuvants in a melanoma vaccine; study has completed.
-
CLINICAL_TRIALS research · 2015-02-10Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery [Phase 2]
A Phase 2 clinical trial update evaluating a vaccine therapy for stage III or stage IV melanoma that cannot be removed with surgery.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma [Phase 3]
An update on a Phase 3 trial evaluating adjuvant interferon alfa-2b following surgery in patients with stage III melanoma. The current trial…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial results are reported for aflibercept (VEGF Trap) in patients with unresectable recurrent melanoma (Stage III or Stage IV), wit…
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1]
This document notes the completion of a Phase 1 clinical trial evaluating a vaccine therapy in patients with stage III or stage IV melanoma.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Inducing Systemic Immunity and Regressions in Metastatic Melanoma [Phase 1]
A Phase 1 clinical trial update reports on a strategy to induce systemic immunity and observe tumor regressions in patients with metastatic …
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-15 after chemotherapy and lymphocyte transfer in metastatic melanoma; the study was terminated and re…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery [Phase 1]
A Phase 1 trial evaluated whether a booster vaccination could prevent recurrence of surgically removed melanoma in patients who had prior va…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. [Phase 1, Phase 2]
This Clinical Trial Update reports the completion of an open-label Phase I/IIa dose-escalation study of 2B3-101 in patients with solid tumor…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma [Phase 2]
Phase II trial investigating extended-dosing temozolomide in melanoma completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma [Phase 1, Phase 2]
A clinical trial update for a phase 1/2 study of a recombinant vaccinia virus (Pexa-Vec/JX-594) in malignant melanoma, sponsored by Jennerex…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of sulindac and epirubicin for metastatic melanoma has completed enrollment.